The trial is for women who have the HER2 gene and have already received treatments, details listed below. BD The Barbara Ann Karmanos Institute is looking for women with HER2 positive metastatic breast cancer to participate in a clinical trial. The Phase II trial at Karmanos is part of an...
One of the first kits on the market, as the article states the test can assess whether breast cancer patients would benefit from Genentech's Herceptin cancer drug. The website as of today asks that you contact a sales person for additional information. BD The test, which received...
More information can be found here. October is breast cancer awareness month. As of today, the site states information is coming soon so check back for any new announcements. You will need to participate in the Curves coaching program for exercise if not already enrolled. Current...
This is a big even in the move towards personalized medicine. This test will allow the physician to determine if the use of Herceptin is the right treatment for the patient with breast cancer! If it is determined not to work, then the patient is spared the expense and use of the drug, and...